Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data.
about
Preventing Cervical Cancer in the United States: Barriers and Resolutions for HPV VaccinationEUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infectionLessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteinsThe immunological underpinnings of vaccinations to prevent cytomegalovirus disease.Early direct and indirect impact of quadrivalent HPV (4HPV) vaccine on genital warts: a systematic reviewPopulation-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysisEvaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort StudyGenital Human Papillomavirus Infection Progression to External Genital Lesions: The HIM Study.Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal)Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study.Testing previous model predictions against new data on human papillomavirus vaccination program outcomes.Psychosocial determinants of parental human papillomavirus (HPV) vaccine decision-making for sons: Methodological challenges and initial results of a pan-Canadian longitudinal study.Impact and Cost-effectiveness of Selective Human Papillomavirus Vaccination of Men Who Have Sex With Men.Application of the Carolina Framework for Cervical Cancer PreventionHuman papillomavirus vaccination: the population impact.Vaccination to prevent human papillomavirus infections: From promise to practice.Is expanding HPV vaccination programs to include school-aged boys likely to be value-for-money: a cost-utility analysis in a country with an existing school-girl program.Incremental benefits of male HPV vaccination: accounting for inequality in population uptake.Insights in public health: The hidden epidemic: sexually transmitted diseases in 2014.Decreased management of genital warts in young women in Australian general practice post introduction of national HPV vaccination program: results from a nationally representative cross-sectional general practice study.Dendritic-cell-based therapeutic cancer vaccinesHuman papilloma virus vaccination: impact and recommendations across the world.Towards the eradication of HPV infection through universal specific vaccination.Educational interventions to increase HPV vaccination acceptance: a systematic review.Effect of human papillomavirus (HPV) vaccination on clinical indicators of sexual behaviour among adolescent girls: the Ontario Grade 8 HPV Vaccine Cohort Study.Immunoprevention of human papillomavirus-associated malignanciesPrevention of HPV-related cancers in Norway: cost-effectiveness of expanding the HPV vaccination program to include pre-adolescent boys.Too late to vaccinate? The incremental benefits and cost-effectiveness of a delayed catch-up program using the 4-valent human papillomavirus vaccine in Norway.Providing comprehensive health services for young key populations: needs, barriers and gapsThe association of human papillomavirus vaccination with sexual behaviours and human papillomavirus knowledge: a systematic review.High rates of sexually transmissible infections in HIV-positive patients in the Australian HIV Observational Database: a prospective cohort study[HPV-induced anal lesions].Human papillomavirus DNA in men who have sex with men: type-specific prevalence, risk factors and implications for vaccination strategies.Incidence of sexually transmitted infections after human papillomavirus vaccination among adolescent females.Evaluation of safety and immunogenicity of a quadrivalent human papillomavirus vaccine in healthy females between 9 and 26 years of age in Sub-Saharan AfricaMapping HPV Vaccination and Cervical Cancer Screening Practice in the Pacific Region-Strengthening National and Regional Cervical Cancer Prevention.Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria.The role of pediatricians as key stakeholders in influencing immunization policy decisions for the introduction of meningitis B vaccine in Canada: The Ontario perspective.Quality of physician communication about human papillomavirus vaccine: findings from a national survey.Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia
P2860
Q26766348-EBC35C2C-00C7-4E5E-BE23-1BF236BC607AQ27010432-9FDBE665-8EF0-4459-A713-5645F03543BAQ27013018-95380681-05E4-4BBC-AEC7-E285E5147CCEQ27692570-D1309A32-F3D4-4EC9-9E5D-0E95F09943B8Q28081927-9450245F-BE91-4A8F-9741-A7F7A591B4EFQ28084924-3EA47517-9AF1-40F4-97B0-75E4AFE41B2DQ28647510-9815D2ED-8D0C-4A74-A217-028FD1A04306Q30279220-374CAA19-B1AB-42EB-99AC-00F60ED891DEQ30566680-A9D418DC-0DA8-41E1-BDF8-FFCA4E0B6201Q30682187-B8CC3B78-40C9-487E-9BA9-F7167670DCE8Q30764433-E80E0643-D8C9-4C17-8139-C9EE07D8FE4EQ30830956-4CFEB864-D116-44B1-9431-D9093AD89C43Q33602635-FD73840F-728A-4C8B-93DC-99D815B7DF61Q33610692-4781AAAC-0300-4D28-8239-D5104A431E02Q33806566-026121CC-5675-4848-8315-77BB5B76A8EBQ33842040-C2C73FFF-54EB-49FB-BD19-08A9D4E64C0DQ33848793-3502054E-0BD6-4E4F-ACB8-27A9758EB812Q33999169-7D2D05F1-B867-4813-8EFB-63C247475A67Q34081308-BF282104-EC03-4D5A-B4FF-ABAED23F8EFCQ34122064-4CCA5E42-47C3-4934-96B1-17DD2A7B48DCQ34360094-F5995D2E-918F-4D60-99D9-EDE67AB37781Q34704575-E54532F3-97A9-45BC-832C-CF005BAFCFB4Q34812959-8F0709B4-EE51-463F-86A5-F486B093F5C2Q34846745-6AC3D2DE-3033-435E-BB68-55B5FA9F624AQ35032459-E5595986-7AFF-47A1-BF2B-675ABF7A8105Q35044376-6C77CC01-2C1A-4E52-902E-885176901A91Q35126586-168BF8E3-7A0F-499A-B545-E8D0D766FC40Q35127307-BDA01004-BE14-40F7-83CE-76DF025DFC53Q35131217-A9138965-2C54-4867-849C-689326CFF42CQ35317939-A91B1185-68F3-4DB5-8AE7-31E904BC2776Q35327194-6367E885-9D6B-4671-A394-7DF6CF3E9884Q35598917-1E467AFB-E452-45D1-A4AC-43814A9C2612Q35677956-06D5440B-D817-4E50-BA43-3FA255F90C3FQ35733501-9D4DBB6B-48CB-46CA-B114-4C88A69AABFAQ35887646-2A060FC9-1F4B-4132-A2BC-0E44A0F87A41Q35888255-54C36F9E-67CA-4A36-B3E1-26AFB6246EFFQ35991580-062FB7C8-BF0D-42D8-9FCA-27A3A8153891Q36015651-0999F0DD-CAA2-488C-9DD7-5C9D7079DB2DQ36249108-A44EC0BA-7239-49C6-A129-8FB3FDDADCA9Q36251151-1CB12083-B4E2-4963-903B-68B17763C3E1
P2860
Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Genital warts in young Austral ...... e: national surveillance data.
@ast
Genital warts in young Austral ...... e: national surveillance data.
@en
type
label
Genital warts in young Austral ...... e: national surveillance data.
@ast
Genital warts in young Austral ...... e: national surveillance data.
@en
prefLabel
Genital warts in young Austral ...... e: national surveillance data.
@ast
Genital warts in young Austral ...... e: national surveillance data.
@en
P2093
P356
P1433
P1476
Genital warts in young Austral ...... e: national surveillance data.
@en
P2093
Andrew E Grulich
Basil Donovan
David G Regan
Hammad Ali
Handan Wand
Tim R H Read
P356
10.1136/BMJ.F2032
P407
P577
2013-04-18T00:00:00Z